Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,881 | Dovepress* | 6,881+ | 2,720 | 9,601 | |
Totals | 6,881 | 2,720 | 9,601 | ||
*Since 8 February 2008 +Since July 2016 |
View citations on Google Scholar